Literature DB >> 7351287

Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.

P T Regan, E P DiMagno.   

Abstract

The coexistence of nontropical sprue and advanced pancreatic insufficiency is uncommon. The purposes of this report are to: (a) describe 3 patients with non-tropical spruc and severe pancreatic insufficiency, (b) determine the frequency, magnitude, and clinical importance of diminished pancreatic secretion in nontropical sprue, and (c) assess whether patients with pancreatic insufficency secondary to chronic pancreatitis or pancreatic cancer have jejunal mucosal histologic abnormalities. In each of 3 patients with nontropical sprue and associated severe exocrine pancreatic insufficiency, an optimal clinical response required the appropriate treatment of both causes of malabsorption. Of 31 subjects with proved nontropical sprue, cholecystokinin-stimulated duodenal tryptic activity or lipolytic activity (or both) was reduced in 13 (42%) but severely reduced in only the three case reports (10%). The morphologic structure of the small bowel was normal in 21 patients with primary pancreatic insufficiency secondary to chronic pancreatitis or pancreatic cancer. Mild-to-moderate exocrine pancreatic insufficiency is a frequent finding in untreated nontropical sprue, is presumably reversible, and rarely contributes to the development of steatorrhea. However, if patients with nontropical sprue fail to respond to a gluten-free diet, coexistent severe pancreatic insufficiency is a possible cause for treatment failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351287

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Celiac sprue among US military veterans: associated disorders and clinical manifestations.

Authors:  F Delcò; H B El-Serag; A Sonnenberg
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation?

Authors:  Kate E Evans; John S Leeds; Stephen Morley; David S Sanders
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

3.  Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.

Authors:  Julian A Abrams; Beverly Diamond; Heidrun Rotterdam; Peter H R Green
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  Celiac disease: management of persistent symptoms in patients on a gluten-free diet.

Authors:  David H Dewar; Suzanne C Donnelly; Simon D McLaughlin; Matthew W Johnson; H Julia Ellis; Paul J Ciclitira
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 5.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 6.  Hepatobiliary and pancreatic disorders in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

7.  Basal and fat-stimulated plasma peptide YY levels in celiac disease.

Authors:  P J Wahab; W P Hopman; J B Jansen
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

8.  Exocrine pancreatic insufficiency after allogeneic bone marrow transplantation.

Authors:  A Maringhini; M A Gertz; E P DiMagno
Journal:  Int J Pancreatol       Date:  1995-06

9.  Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.

Authors:  D J Moore; G G Forstner; C Largman; G J Cleghorn; S S Wong; P R Durie
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

10.  Histological variations of the duodenal mucosa in chronic human pancreatitis.

Authors:  F Senegas-Balas; M J Bastie; D Balas; J Escourrou; G Bommelaer; C Bertrand; Y Arany; A Ribet
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.